Bu öğeden alıntı yapmak, öğeye bağlanmak için bu tanımlayıcıyı kullanınız:
http://hdl.handle.net/11452/26685
Tüm üstveri kaydı
Dublin Core Alanı | Değer | Dil |
---|---|---|
dc.date.accessioned | 2022-05-25T10:51:08Z | - |
dc.date.available | 2022-05-25T10:51:08Z | - |
dc.date.issued | 2012-10 | - |
dc.identifier.citation | Turan, A. B. vd. (2012). "Vulnerability of an epileptic case to psychosis: Sodium valproate with lamotrigine, forced normalization, postictal psychosis or all". Neurological Sciences, 33(5), 1161-1163. | en_US |
dc.identifier.issn | 1590-1874 | - |
dc.identifier.uri | https://doi.org/10.1007/s10072-011-0869-9 | - |
dc.identifier.uri | https://link.springer.com/article/10.1007/s10072-011-0869-9 | - |
dc.identifier.uri | http://hdl.handle.net/11452/26685 | - |
dc.description.abstract | Patients with epilepsy can be considered to be at high risk for developing psychotic disorders. Furthermore, there is association between seizure freedom or the disappearance of the interictal epileptiform events from the EEG record and the occurrence of psychotic symptoms. Also, several newer antiepileptic drugs have been reported to induce psychotic symptoms. We present a patient with epilepsy who developed psychotic symptoms under the treatment of valproic acid (VPA) and lamotrigine (LTG) combination. The mechanism underlying the association between LTG, seizure control and development of psychosis are discussed in the light of the literature. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Springer | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Neurosciences & neurology | en_US |
dc.subject | Epilepsy | en_US |
dc.subject | Psychosis | en_US |
dc.subject | Lamotrigine | en_US |
dc.subject | Valproic acid | en_US |
dc.subject | Forced normalization | en_US |
dc.subject | Of-the-literature | en_US |
dc.subject | Risk | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Age of onset | en_US |
dc.subject.mesh | Anticonvulsants | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Drug therapy, combination | en_US |
dc.subject.mesh | Electroencephalography | en_US |
dc.subject.mesh | Epilepsy | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Psychotic disorders | en_US |
dc.subject.mesh | Triazines | en_US |
dc.subject.mesh | Valproic acid | en_US |
dc.title | Vulnerability of an epileptic case to psychosis: Sodium valproate with lamotrigine, forced normalization, postictal psychosis or all | en_US |
dc.type | Article | en_US |
dc.identifier.wos | 000308819000027 | tr_TR |
dc.identifier.scopus | 2-s2.0-84869212154 | tr_TR |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi | tr_TR |
dc.contributor.department | Uludağ Üniversitesi/Tıp Fakültesi/Nöroloji Anabilim Dalı. | tr_TR |
dc.contributor.orcid | 0000-0003-4436-3797 | tr_TR |
dc.identifier.startpage | 1161 | tr_TR |
dc.identifier.endpage | 1163 | tr_TR |
dc.identifier.volume | 33 | tr_TR |
dc.identifier.issue | 5 | tr_TR |
dc.relation.journal | Neurological Sciences | en_US |
dc.contributor.buuauthor | Turan, Aslı Bahar | - |
dc.contributor.buuauthor | Seferoǧlu, Meral | - |
dc.contributor.buuauthor | Taşkapılıoğlu, Özlem | - |
dc.contributor.buuauthor | Bora, İbrahim | - |
dc.contributor.researcherid | X-4479-2018 | tr_TR |
dc.contributor.researcherid | AAK-6623-2020 | tr_TR |
dc.identifier.pubmed | 22131039 | tr_TR |
dc.subject.wos | Clinical neurology | en_US |
dc.subject.wos | Neurosciences | en_US |
dc.indexed.wos | SCIE | en_US |
dc.indexed.scopus | Scopus | en_US |
dc.indexed.pubmed | PubMed | en_US |
dc.wos.quartile | Q3 | en_US |
dc.contributor.scopusid | 53664547900 | tr_TR |
dc.contributor.scopusid | 25636262100 | tr_TR |
dc.contributor.scopusid | 23037226400 | tr_TR |
dc.contributor.scopusid | 6602914249 | tr_TR |
dc.subject.scopus | Patient with Epilepsy; Temporal Lobe Epilepsy; Drug Resistant Epilepsy | en_US |
dc.subject.emtree | Electrolyte | en_US |
dc.subject.emtree | Etiracetam | en_US |
dc.subject.emtree | Lamotrigine | en_US |
dc.subject.emtree | Risperidone | en_US |
dc.subject.emtree | Valproic acid | en_US |
dc.subject.emtree | Zonisamide | en_US |
dc.subject.emtree | Absence | en_US |
dc.subject.emtree | Add on therapy | en_US |
dc.subject.emtree | Adult | en_US |
dc.subject.emtree | Agitation | en_US |
dc.subject.emtree | Anticonvulsant therapy | en_US |
dc.subject.emtree | Article | en_US |
dc.subject.emtree | Case report | en_US |
dc.subject.emtree | Common cold symptom | en_US |
dc.subject.emtree | Confusion | en_US |
dc.subject.emtree | Consultation | en_US |
dc.subject.emtree | Disease severity | en_US |
dc.subject.emtree | Drug dose increase | en_US |
dc.subject.emtree | Drug substitution | en_US |
dc.subject.emtree | Dsm-IV | en_US |
dc.subject.emtree | Electroencephalogram | en_US |
dc.subject.emtree | Epileptic state | en_US |
dc.subject.emtree | Follow up | en_US |
dc.subject.emtree | Generalized epilepsy | en_US |
dc.subject.emtree | Human | en_US |
dc.subject.emtree | Idiopathic generalized epilepsy | en_US |
dc.subject.emtree | Laboratory test | en_US |
dc.subject.emtree | Male | en_US |
dc.subject.emtree | Outpatient care | en_US |
dc.subject.emtree | Paranoia | en_US |
dc.subject.emtree | Patient transport | en_US |
dc.subject.emtree | Psychiatric department | en_US |
dc.subject.emtree | Psychiatrist | en_US |
dc.subject.emtree | Psychosis | en_US |
dc.subject.emtree | Seizure | en_US |
dc.subject.emtree | Side effect | en_US |
dc.subject.emtree | Sleep disorder | en_US |
dc.subject.emtree | Thought disorder | en_US |
Koleksiyonlarda Görünür: | Scopus Web of Science |
Bu öğenin dosyaları:
Bu öğeyle ilişkili dosya bulunmamaktadır.
DSpace'deki bütün öğeler, aksi belirtilmedikçe, tüm hakları saklı tutulmak şartıyla telif hakkı ile korunmaktadır.